5CA-51067-86268
3 vaccinations
10 coded responses
26 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 082 / NJ
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Survey response — day 0, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Significant bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Significant bruising at the injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Still have significant bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Significant bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site discolouration — Feeling: GoodFree text: Significant Injection site bruising, more purple todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Still have signify the bruising at injection site. Doesnt seem to be dissipating as quickly as normal bruise.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Significant Bruise at injection site starting to dissipate but still very angry lookingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — day 7, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Significant bruise still exists at injection site. Hasnt dissipated as normal bruise. 1 wk out.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
-
2021-02-16
Dose 2 — Pfizer-BioNTech
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-18
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-05-18
- 2021-08-19
-
2021-10-17
Dose 3 — Pfizer-BioNTech
- 2022-02-16
-
2022-04-23
Survey response — 6 months, dose 3MedDRA: Antiacetylcholine receptor antibody positive, Office visit, Ophthalmic migraine, Visual impairment — Feeling: GoodFree text: Kaleidoscope vision which lasted 5-10 mins 4 x in 4 wks starting Jan24,2022. Blood test showed elevated AChR (blocking), potential Dx ocular Myasthenia gravis. Went to specialist at (b)(6) Neuro-Opthamolgist). Dx ocular migraines.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Survey response — 12 months, dose 3MedDRA: Ophthalmic migraine, Scintillating scotoma — Feeling: GoodFree text: scintillating scotoma due to ocular migrainesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-10-17 | Pfizer-BioNTech | No |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Significant bruise at injection site
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Significant bruising at the injection site.
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Still have significant bruise at injection site
Systemic reaction (other): Significant bruising at injection site
Systemic reaction (other): Significant Injection site bruising, more purple today
Systemic reaction (other): Still have signify the bruising at injection site. Doesnt seem to be dissipating as quickly as normal bruise.
Systemic reaction (other): Significant Bruise at injection site starting to dissipate but still very angry looking
Release 3 — day 7, dose 1
Systemic reaction (other): Significant bruise still exists at injection site. Hasnt dissipated as normal bruise. 1 wk out.
Release 11 — 6 months, dose 3
Symptoms: Kaleidoscope vision which lasted 5-10 mins 4 x in 4 wks starting Jan24,2022. Blood test showed elevated AChR (blocking), potential Dx ocular Myasthenia gravis. Went to specialist at (b)(6) Neuro-Opthamolgist). Dx ocular migraines.
redacted (b)(6)
Release 12 — 12 months, dose 3
Symptoms: scintillating scotoma due to ocular migraines
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Antiacetylcholine receptor antibody positive | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Ophthalmic migraine | · | · | ✓ |
| SD | Scintillating scotoma | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site discolouration | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release